Project Details
Description
A Double-blinded, Randomized, Placebo-Controlled Phase III Study to assess the efficacy of reMAGE-A3 + AS15 ASCI as Adjuvant therapy in Patients with MAGE-A3 Positive Resected Stage III Melanoma
| Status | Finished |
|---|---|
| Effective start/end date | 7/31/08 → 7/31/13 |
Funding
- GLAXOSMITHKLINE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.